274 related articles for article (PubMed ID: 30518612)
1. A human-derived antibody targets misfolded SOD1 and ameliorates motor symptoms in mouse models of amyotrophic lateral sclerosis.
Maier M; Welt T; Wirth F; Montrasio F; Preisig D; McAfoose J; Vieira FG; Kulic L; Späni C; Stehle T; Perrin S; Weber M; Hock C; Nitsch RM; Grimm J
Sci Transl Med; 2018 Dec; 10(470):. PubMed ID: 30518612
[TBL] [Abstract][Full Text] [Related]
2. Distinct conformers of transmissible misfolded SOD1 distinguish human SOD1-FALS from other forms of familial and sporadic ALS.
Ayers JI; Diamond J; Sari A; Fromholt S; Galaleldeen A; Ostrow LW; Glass JD; Hart PJ; Borchelt DR
Acta Neuropathol; 2016 Dec; 132(6):827-840. PubMed ID: 27704280
[TBL] [Abstract][Full Text] [Related]
3. The molecular tweezer CLR01 inhibits aberrant superoxide dismutase 1 (SOD1) self-assembly
Malik R; Meng H; Wongkongkathep P; Corrales CI; Sepanj N; Atlasi RS; Klärner FG; Schrader T; Spencer MJ; Loo JA; Wiedau M; Bitan G
J Biol Chem; 2019 Mar; 294(10):3501-3513. PubMed ID: 30602569
[TBL] [Abstract][Full Text] [Related]
4. Wild-type Cu/Zn-superoxide dismutase is misfolded in cerebrospinal fluid of sporadic amyotrophic lateral sclerosis.
Tokuda E; Takei YI; Ohara S; Fujiwara N; Hozumi I; Furukawa Y
Mol Neurodegener; 2019 Nov; 14(1):42. PubMed ID: 31744522
[TBL] [Abstract][Full Text] [Related]
5. ALS-linked misfolded SOD1 species have divergent impacts on mitochondria.
Pickles S; Semmler S; Broom HR; Destroismaisons L; Legroux L; Arbour N; Meiering E; Cashman NR; Vande Velde C
Acta Neuropathol Commun; 2016 Apr; 4(1):43. PubMed ID: 27121871
[TBL] [Abstract][Full Text] [Related]
6. AAV2/9-mediated overexpression of MIF inhibits SOD1 misfolding, delays disease onset, and extends survival in mouse models of ALS.
Leyton-Jaimes MF; Kahn J; Israelson A
Proc Natl Acad Sci U S A; 2019 Jul; 116(29):14755-14760. PubMed ID: 31262807
[TBL] [Abstract][Full Text] [Related]
7. Misfolded SOD1 is not a primary component of sporadic ALS.
Da Cruz S; Bui A; Saberi S; Lee SK; Stauffer J; McAlonis-Downes M; Schulte D; Pizzo DP; Parone PA; Cleveland DW; Ravits J
Acta Neuropathol; 2017 Jul; 134(1):97-111. PubMed ID: 28247063
[TBL] [Abstract][Full Text] [Related]
8. Targeting of monomer/misfolded SOD1 as a therapeutic strategy for amyotrophic lateral sclerosis.
Liu HN; Tjostheim S; Dasilva K; Taylor D; Zhao B; Rakhit R; Brown M; Chakrabartty A; McLaurin J; Robertson J
J Neurosci; 2012 Jun; 32(26):8791-9. PubMed ID: 22745481
[TBL] [Abstract][Full Text] [Related]
9. Endogenous macrophage migration inhibitory factor reduces the accumulation and toxicity of misfolded SOD1 in a mouse model of ALS.
Leyton-Jaimes MF; Benaim C; Abu-Hamad S; Kahn J; Guetta A; Bucala R; Israelson A
Proc Natl Acad Sci U S A; 2016 Sep; 113(36):10198-203. PubMed ID: 27551074
[TBL] [Abstract][Full Text] [Related]
10. Toll-Like Receptor-4 Inhibitor TAK-242 Attenuates Motor Dysfunction and Spinal Cord Pathology in an Amyotrophic Lateral Sclerosis Mouse Model.
Fellner A; Barhum Y; Angel A; Perets N; Steiner I; Offen D; Lev N
Int J Mol Sci; 2017 Aug; 18(8):. PubMed ID: 28763002
[TBL] [Abstract][Full Text] [Related]
11. Transglutaminase 2 accelerates neuroinflammation in amyotrophic lateral sclerosis through interaction with misfolded superoxide dismutase 1.
Oono M; Okado-Matsumoto A; Shodai A; Ido A; Ohta Y; Abe K; Ayaki T; Ito H; Takahashi R; Taniguchi N; Urushitani M
J Neurochem; 2014 Feb; 128(3):403-18. PubMed ID: 24032595
[TBL] [Abstract][Full Text] [Related]
12. Endoplasmic reticulum stress leads to accumulation of wild-type SOD1 aggregates associated with sporadic amyotrophic lateral sclerosis.
Medinas DB; Rozas P; Martínez Traub F; Woehlbier U; Brown RH; Bosco DA; Hetz C
Proc Natl Acad Sci U S A; 2018 Aug; 115(32):8209-8214. PubMed ID: 30038021
[TBL] [Abstract][Full Text] [Related]
13. A copper-deficient form of mutant Cu/Zn-superoxide dismutase as an early pathological species in amyotrophic lateral sclerosis.
Tokuda E; Nomura T; Ohara S; Watanabe S; Yamanaka K; Morisaki Y; Misawa H; Furukawa Y
Biochim Biophys Acta Mol Basis Dis; 2018 Jun; 1864(6 Pt A):2119-2130. PubMed ID: 29551730
[TBL] [Abstract][Full Text] [Related]
14. Treatment with an antibody directed against Nogo-A delays disease progression in the SOD1G93A mouse model of Amyotrophic lateral sclerosis.
Bros-Facer V; Krull D; Taylor A; Dick JR; Bates SA; Cleveland MS; Prinjha RK; Greensmith L
Hum Mol Genet; 2014 Aug; 23(16):4187-200. PubMed ID: 24667415
[TBL] [Abstract][Full Text] [Related]
15. CNS-derived extracellular vesicles from superoxide dismutase 1 (SOD1)
Silverman JM; Christy D; Shyu CC; Moon KM; Fernando S; Gidden Z; Cowan CM; Ban Y; Stacey RG; Grad LI; McAlary L; Mackenzie IR; Foster LJ; Cashman NR
J Biol Chem; 2019 Mar; 294(10):3744-3759. PubMed ID: 30635404
[TBL] [Abstract][Full Text] [Related]
16. Spinal cord homogenates from SOD1 familial amyotrophic lateral sclerosis induce SOD1 aggregation in living cells.
Pokrishevsky E; Hong RH; Mackenzie IR; Cashman NR
PLoS One; 2017; 12(9):e0184384. PubMed ID: 28877271
[TBL] [Abstract][Full Text] [Related]
17. Early upregulation of cytosolic phospholipase A
Malada Edelstein YF; Solomonov Y; Hadad N; Alfahel L; Israelson A; Levy R
J Neuroinflammation; 2021 Nov; 18(1):274. PubMed ID: 34823547
[TBL] [Abstract][Full Text] [Related]
18. TNF receptor-associated factor 6 interacts with ALS-linked misfolded superoxide dismutase 1 and promotes aggregation.
Semmler S; Gagné M; Garg P; Pickles SR; Baudouin C; Hamon-Keromen E; Destroismaisons L; Khalfallah Y; Chaineau M; Caron E; Bayne AN; Trempe JF; Cashman NR; Star AT; Haqqani AS; Durcan TM; Meiering EM; Robertson J; Grandvaux N; Plotkin SS; McBride HM; Vande Velde C
J Biol Chem; 2020 Mar; 295(12):3808-3825. PubMed ID: 32029478
[TBL] [Abstract][Full Text] [Related]
19. An immunological epitope selective for pathological monomer-misfolded SOD1 in ALS.
Rakhit R; Robertson J; Vande Velde C; Horne P; Ruth DM; Griffin J; Cleveland DW; Cashman NR; Chakrabartty A
Nat Med; 2007 Jun; 13(6):754-9. PubMed ID: 17486090
[TBL] [Abstract][Full Text] [Related]
20. Knocking down metabotropic glutamate receptor 1 improves survival and disease progression in the SOD1(G93A) mouse model of amyotrophic lateral sclerosis.
Milanese M; Giribaldi F; Melone M; Bonifacino T; Musante I; Carminati E; Rossi PI; Vergani L; Voci A; Conti F; Puliti A; Bonanno G
Neurobiol Dis; 2014 Apr; 64():48-59. PubMed ID: 24361555
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
